{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,16]],"date-time":"2026-05-16T13:52:17Z","timestamp":1778939537101,"version":"3.51.4"},"reference-count":35,"publisher":"MDPI AG","issue":"16","license":[{"start":{"date-parts":[[2024,8,15]],"date-time":"2024-08-15T00:00:00Z","timestamp":1723680000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"University of Oviedo","award":["PAPI-18-EMERG-5"],"award-info":[{"award-number":["PAPI-18-EMERG-5"]}]},{"name":"Asturias Regional Nursing Council","award":["PAPI-18-EMERG-5"],"award-info":[{"award-number":["PAPI-18-EMERG-5"]}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Cancers"],"abstract":"<jats:p>During breast cancer (BC), cardiometabolic disorders can worsen prognosis, particularly in women with type 2 diabetes mellitus (T2DM). This study aimed to determine the impact of BC diagnosis on cardiometabolic parameters and the incidence of complication in women over 50 years of age (90% aged \u2265 65 years) with pre-existing T2DM. Using primary care registries from Asturias (Spain), a total of 106 women diagnosed with T2DM followed by BC were selected and matched with women with T2DM (n = 212) in a cohort study. Indicators of cardiometabolic health and microvascular complications associated with T2DM were collected. Women were monitored from two years prior to five years after BC diagnosis. Conditional logistic regressions were used to compare the adjusted odds of staying below each indicator\u2019s threshold. During follow-up, women with T2DM+BC had a higher risk of fasting blood glucose \u2265126 mg\/dL (adjusted odds ratio [aOR] = 1.83; 95% confidence interval [CI95%]: 1.01\u20133.32) and glycosylated hemoglobin (Hb1Ac) \u2265 48 mmol\/mol or 6.5% (aOR: 2.44; IC95%: 1.21\u20134.91). There was no difference between the groups regarding the incidence of microvascular complications. BC incidence negatively impacted the glycemic control of Spanish women with pre-existing T2DM measured by basal blood glucose and HbA1c, but not cardiometabolic health indicators or T2DM complications.<\/jats:p>","DOI":"10.3390\/cancers16162853","type":"journal-article","created":{"date-parts":[[2024,8,16]],"date-time":"2024-08-16T04:29:57Z","timestamp":1723782597000},"page":"2853","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Impact of Breast Cancer on Cardiometabolic Health in Spanish Women \u226550 Years with Pre-Existing Type 2 Diabetes Mellitus"],"prefix":"10.3390","volume":"16","author":[{"given":"Luc\u00eda","family":"Fern\u00e1ndez-Arce","sequence":"first","affiliation":[{"name":"Department of Medicine, Faculty of Medicine and Health Sciences, University of Oviedo\/ISPA, 33006 Oviedo, Spain"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nena","family":"Robles-Rodr\u00edguez","sequence":"additional","affiliation":[{"name":"Department of Medicine, Faculty of Medicine and Health Sciences, University of Oviedo\/ISPA, 33006 Oviedo, Spain"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5718-0570","authenticated-orcid":false,"given":"Ana","family":"Fern\u00e1ndez-Feito","sequence":"additional","affiliation":[{"name":"Department of Medicine, Faculty of Medicine and Health Sciences, University of Oviedo\/ISPA, 33006 Oviedo, Spain"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Roc\u00edo","family":"Fern\u00e1ndez-Iglesias","sequence":"additional","affiliation":[{"name":"Department of Medicine, Faculty of Medicine and Health Sciences, University of Oviedo\/ISPA, 33006 Oviedo, Spain"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4603-2289","authenticated-orcid":false,"given":"Mar\u00eda del Mar","family":"Fern\u00e1ndez-\u00c1lvarez","sequence":"additional","affiliation":[{"name":"Department of Surgery and Medical Surgical Specialities, Faculty of Medicine and Health Sciences, University of Oviedo\/ISPA, 33006 Oviedo, Spain"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alberto","family":"Lana","sequence":"additional","affiliation":[{"name":"Department of Medicine, Faculty of Medicine and Health Sciences, University of Oviedo\/ISPA, 33006 Oviedo, Spain"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1968","published-online":{"date-parts":[[2024,8,15]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"1608","DOI":"10.1038\/bjc.2012.414","article-title":"Diabetes and breast cancer risk: A meta-analysis","volume":"107","author":"Boyle","year":"2012","journal-title":"Br. J. Cancer"},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"1421","DOI":"10.1002\/bjs.9229","article-title":"Systematic review and meta-analysis of the association between diabetes mellitus and incidence and mortality in breast and colorectal cancer","volume":"100","author":"Arends","year":"2013","journal-title":"Br. J. Surg."},{"key":"ref_3","first-page":"101","article-title":"Diabetes mellitus is associated with breast cancer: Systematic review, meta-analysis, and in silico reproduction","volume":"57","author":"Zhou","year":"2015","journal-title":"Panminerva Med."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"23","DOI":"10.5662\/wjm.v11.i3.23","article-title":"Epidemiological link between obesity, type 2 diabetes mellitus and cancer","volume":"11","author":"Fernandez","year":"2021","journal-title":"World J. Methodol."},{"key":"ref_5","first-page":"1061","article-title":"Association between diabetes mellitus and breast cancer risk: A meta-analysis of the literature","volume":"12","author":"Liao","year":"2011","journal-title":"Asian Pac. J. Cancer Prev."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1016\/j.jcjd.2017.02.005","article-title":"The Relation of Type 2 Diabetes and Breast Cancer Incidence in Asian, Hispanic and African American Populations\u2014A Review","volume":"42","author":"Maskarinec","year":"2018","journal-title":"Can. J. Diabetes"},{"key":"ref_7","doi-asserted-by":"crossref","unstructured":"Soltani, S., Abdollahi, S., Aune, D., and Jayedi, A. (2021). Body mass index and cancer risk in patients with type 2 diabetes: A dose-response meta-analysis of cohort studies. Sci. Rep., 11.","DOI":"10.1038\/s41598-021-81671-0"},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"829","DOI":"10.2174\/1568009621666210901101851","article-title":"A molecular link between diabetes and breast cancer: Therapeutic potential of repurposing incretin-based therapies for breast cancer","volume":"21","author":"Jaiswal","year":"2021","journal-title":"Curr. Cancer Drug Targets"},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1186\/s12935-021-02040-5","article-title":"The prognostic outcome of \u2018type 2 diabetes mellitus and breast cancer\u2019 association pivots on hypoxia-hyperglycemia axis","volume":"21","author":"Durrani","year":"2021","journal-title":"Cancer Cell Int."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"R35","DOI":"10.1530\/JOE-18-0037","article-title":"Metabolic reprogramming in type 2 diabetes and the development of breast cancer","volume":"237","author":"Martin","year":"2018","journal-title":"J. Endocrinol."},{"key":"ref_11","doi-asserted-by":"crossref","unstructured":"Zhang, F., de Haan-Du, J., Sidorenkov, G., Landman, G.W.D., Jalving, M., Zhang, Q., and Bock, G. (2021). Type 2 Diabetes Mellitus and Clinicopathological Tumor Characteristics in Women Diagnosed with Breast Cancer: A Systematic Review and Meta-Analysis. Cancers, 13.","DOI":"10.3390\/cancers13194992"},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"108249","DOI":"10.1016\/j.jdiacomp.2022.108249","article-title":"Influence of type 2 diabetes mellitus on mortality in women with breast cancer: A matched case-control study","volume":"36","author":"Romero","year":"2022","journal-title":"J. Diabetes Complicat."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1007\/s10238-018-0497-2","article-title":"Good glycaemic control is associated with a better prognosis in breast cancer patients with type 2 diabetes mellitus","volume":"18","author":"Chang","year":"2018","journal-title":"Clin. Exp. Med."},{"key":"ref_14","doi-asserted-by":"crossref","unstructured":"American Diabetes Association (2021). Summary of Revisions: Standards of Medical Care in Diabetes-2021. Diabetes Care, 44, S4\u2013S6.","DOI":"10.2337\/dc21-Srev"},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1007\/s10549-021-06324-2","article-title":"Symptoms associated with comorbid diabetes among breast cancer survivors","volume":"189","author":"Coughlin","year":"2021","journal-title":"Breast Cancer Res. Treat."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1016\/j.ejso.2012.02.179","article-title":"Risk factors for surgical site infections after breast surgery: A systematic review and meta-analysis","volume":"38","author":"Xue","year":"2012","journal-title":"Eur. J. Surg. Oncol."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1007\/s10549-018-5025-2","article-title":"Type 2 diabetes as a predictor of survival among breast cancer patients: The multiethnic cohort","volume":"173","author":"Maskarinec","year":"2019","journal-title":"Breast Cancer Res. Treat."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1007\/s10552-021-01526-x","article-title":"Type 2 Diabetes and all-cause mortality among Spanish women with breast cancer","volume":"33","author":"Lana","year":"2022","journal-title":"Cancer Causes Control"},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"101710","DOI":"10.1016\/j.canep.2020.101710","article-title":"Impact of preexisting type 2 diabetes mellitus and antidiabetic drugs on all-cause and cause-specific mortality among Medicaid-insured women diagnosed with breast cancer","volume":"66","author":"Lawrence","year":"2020","journal-title":"Cancer Epidemiol."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1007\/s10549-014-3146-9","article-title":"Diabetes, diabetes treatment and breast cancer prognosis","volume":"148","author":"Luo","year":"2014","journal-title":"Breast Cancer Res. Treat."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1038\/s41523-018-0099-x","article-title":"Fructosamine and diabetes as predictors of mortality among Hispanic and non-Hispanic white breast cancer survivors","volume":"5","author":"Connor","year":"2019","journal-title":"NPJ Breast Cancer"},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1200\/JCO.2010.29.3183","article-title":"Clinically defined type 2 diabetes mellitus and prognosis in early-stage breast cancer","volume":"29","author":"Erickson","year":"2011","journal-title":"J. Clin. Oncol."},{"key":"ref_23","first-page":"732027","article-title":"Impact of diabetes and hyperglycemia on survival in advanced breast cancer patients","volume":"2012","author":"Bacon","year":"2012","journal-title":"Exp. Diabetes Res."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"3881","DOI":"10.1016\/j.ejca.2013.08.004","article-title":"High fasting blood glucose and obesity significantly and independently increase risk of breast cancer death in hormone receptor-positive disease","volume":"49","author":"Minicozzi","year":"2013","journal-title":"Eur. J. Cancer"},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1093\/intqhc\/mzy124","article-title":"Quality of diabetes care in cancer: A systematic review","volume":"31","author":"Griffiths","year":"2019","journal-title":"Int. J. Qual. Health Care"},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"3801","DOI":"10.1210\/en.2018-00574","article-title":"Diabetes, Obesity, and Breast Cancer","volume":"159","author":"Kang","year":"2018","journal-title":"Endocrinology"},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1002\/pds.3660","article-title":"Adherence to oral diabetes medications and glycemic control during and following breast cancer treatment","volume":"24","author":"Calip","year":"2015","journal-title":"Pharmacoepidemiol. Drug Saf."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1007\/s11764-018-0717-5","article-title":"Quality of diabetes care in breast, colorectal, and prostate cancer","volume":"12","author":"Griffiths","year":"2018","journal-title":"J. Cancer Surviv."},{"key":"ref_29","doi-asserted-by":"crossref","unstructured":"Samuel, S.M., Varghese, E., Kubatka, P., Triggle, C.R., and B\u00fcsselberg, D. (2019). Metformin: The Answer to Cancer in a Flower? Current Knowledge and Future Prospects of Metformin as an Anti-Cancer Agent in Breast Cancer. Biomolecules, 9.","DOI":"10.3390\/biom9120846"},{"key":"ref_30","doi-asserted-by":"crossref","unstructured":"Lv, Z., and Guo, Y. (2020). Metformin and Its Benefits for Various Diseases. Front. Endocrinol., 11.","DOI":"10.3389\/fendo.2020.00191"},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"779","DOI":"10.1177\/0145721712458835","article-title":"Perceived impact of cancer treatment on diabetes self-management","volume":"38","author":"Hershey","year":"2012","journal-title":"Diabetes Educ."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"604","DOI":"10.1007\/s11764-017-0631-2","article-title":"Outcomes of preexisting diabetes mellitus in breast, colorectal, and prostate cancer","volume":"11","author":"Griffiths","year":"2017","journal-title":"J. Cancer Surviv."},{"key":"ref_33","doi-asserted-by":"crossref","unstructured":"Scaioli, G., Sch\u00e4fer, W.L.A., Boerma, W.G.W., Spreeuwenberg, P.M.M., Schellevis, F.G., and Groenewegen, P.P. (2020). Communication between general practitioners and medical specialists in the referral process: A cross-sectional survey in 34 countries. BMC Fam. Pract., 21.","DOI":"10.1186\/s12875-020-01124-x"},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"105998","DOI":"10.1016\/j.cct.2020.105998","article-title":"Improving health engagement and lifestyle management for breast cancer survivors with diabetes","volume":"92","author":"Shelby","year":"2020","journal-title":"Contemp. Clin. Trials"},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"1012","DOI":"10.2337\/dc12-1020","article-title":"Age at menopause, reproductive life span, and type 2 diabetes risk: Results from the EPIC-InterAct study","volume":"36","author":"Brand","year":"2013","journal-title":"Diabetes Care"}],"container-title":["Cancers"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2072-6694\/16\/16\/2853\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T15:37:18Z","timestamp":1760110638000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2072-6694\/16\/16\/2853"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,8,15]]},"references-count":35,"journal-issue":{"issue":"16","published-online":{"date-parts":[[2024,8]]}},"alternative-id":["cancers16162853"],"URL":"https:\/\/doi.org\/10.3390\/cancers16162853","relation":{},"ISSN":["2072-6694"],"issn-type":[{"value":"2072-6694","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,8,15]]}}}